Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
151 studies found for:    Open Studies | "Hyperlipidemias"
Show Display Options
Rank Status Study
1 Available Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: rosuvastatin,fenofibrate;   Genetic: CYP2C9, UGT1A1, UGT1A3, OATP2, BCRP
2 Not yet recruiting Acupuncture and Moxibustion for Hyperlipemia
Condition: Hyperlipidemias
Interventions: Other: acupuncture and moxibustion;   Drug: Simvastatin;   Other: Therapeutic Lifestyle Change
3 Recruiting Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
Condition: Hyperlipidemia
Intervention: Drug: TAK-085
4 Recruiting A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
5 Recruiting Hyperlipidemia Therapy TERCET Zabrze Registry
Conditions: Hyperlipidemias;   Secondary Prevention
Intervention:
6 Recruiting Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Condition: Hyperlipidemias
Interventions: Drug: Antroquinonol;   Drug: placebo
7 Recruiting A Double-blind, Randomized Study in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia
Condition: Diabetes, Hyperlipidemia, Mixed Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Drug: Atorvastatin;   Other: Placebo
8 Not yet recruiting Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia
Condition: Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
9 Recruiting Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: Atorvastatin 20 mg;   Drug: Cholestyramine 8 g;   Drug: Omega-3 2g;   Drug: Concurrent with Atorvastatin 5 mg + Ezetimibe 10 mg;   Behavioral: Lifestyle modification
10 Recruiting Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
Conditions: Hypertension;   Hyperlipidemia
Interventions: Drug: Temisartan+Amlodipine+Rosuvastatin (Combination drug);   Drug: Temisartan+Amlodipine;   Drug: Temisartan+Rosuvastatin
11 Not yet recruiting Nutraceuticals to Improve Lipid Profile in European Countries
Condition: Hyperlipidemia
Interventions: Behavioral: Non-pharmacologic intervention;   Drug: Nutraceuticals (Armolipid Plus)
12 Recruiting Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride
Condition: Hyperlipidemias
Interventions: Dietary Supplement: Angelica gigas N. extract;   Dietary Supplement: Placebo
13 Recruiting A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
Conditions: Hypertension;   Hyperlipidemias
Interventions: Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg;   Drug: Olmesartan 40 mg, Rosuvastatin 20mg;   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug)
14 Recruiting Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
Condition: Hyperlipidemia
Interventions: Drug: TAK-085;   Other: Not treated with omega-3-acid ethyl esters
15 Recruiting Effect of Butter & MCT Oil on Lipoproteins - A RCT
Condition: Hyperlipidemia
Intervention: Dietary Supplement: MCT oil + Butter in Coffee
16 Recruiting Acute Microvascular Changes With LDL Apheresis
Condition: Hyperlipidemia
Intervention: Procedure: Plasmapharesis
17 Recruiting Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Condition: Hyperlipidemia
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
18 Recruiting Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
Condition: Hyperlipidemias
Interventions: Drug: HCP1105;   Drug: HGP0816;   Drug: Placebo of HCP1105;   Drug: Placebo of HGP0816
19 Recruiting Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
Condition: Hyperlipidemia
Intervention: Drug: Atorvastatin
20 Not yet recruiting A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)
Condition: Hyperlipidemias
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.